黄褐斑发病机制最新研究进展

摘要/Abstract

摘要：黄褐斑为面部对称性黄褐色色素沉着斑,相对常见且易复发,严重影响患者的外观和心理健康。黄褐斑的病因及发病机制复杂,国内外学者对其发病机制进行了不断的研究。尽管存在争议,但大多数学者认为遗传学、紫外线(UV)暴露和性激素水平在启动和维持色素表型方面起着关键的作用。最近研究发现,真皮因素、microRNAs(miRNAs)、氧自由基(ROS)在促进黄褐斑的发生发展中也起着一定作用。为进一步研究黄褐斑发病的可能因素,并对黄褐斑的预防、治疗及减少复发提供帮助,故就黄褐斑的病因和最新发病机制作一综述,重点介绍遗传易感性、紫外线暴露、激素水平、ROS及真皮因素在黄褐斑发病中的作用。

中图分类号:

R751

吴嘉惠, 刘志超. 黄褐斑发病机制最新研究进展[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(6): 471-475.

参考文献

[1] D'Elia MP,Brand o MC,de Andrade Ramos BR,et al.African ancestry is associated with facial melasma in women: a cross-sectional study[J].BMC Med Genet, 2017,18(1):17.
[2] Holmo NF, Ramos GB, Salom o H, et al.Complex segregation analysis of facial melasma in Brazil: evidence for a genetic susceptibility with a dominant pattern of segregation[J].Arch Dermatol Res,2018,310(10):827-831.
[3] Suryaningsih BE,Sadewa AH,Wirohadidjojo YW,et al.Association between heterozygote Val92MetMC1R gene polymorphisms with incidence of melasma: a study of Javanese women population in Yogyakarta[J].Clin Cosmet Investig Dermatol,2019,12:489-495.
[4] Handa S, De D, Khullar G,et al.The clinicoaetiological, hormonal and histopathological characteristics of melasma in men[J].Clin Exp Dermatol,2018,43(1):36-41.
[5] Sun Min,Xie Hong-Fu,Tang Yan, et al.G protein-coupled estrogen receptor enhances melanogenesis via cAMP-protein kinase (PKA) by upregulating microphthalmia-related transcription factor-tyrosinase in melanoma[J]. The Journal of steroid biochemistry and molecular biology,2017,165.
[6] Campuzano-García AE, Torres-Alvarez B, Hernández-Blanco D, et al.DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo[J].Biomed Res Int,2019:9068314.
[7] Mione M, Bosserhoff A. MicroRNAs in melanocyte and melanoma biology[J].Pigment Cell Melanoma Res,2015,28(3):340-354
[8] Kim NH, Choi SH, Yi N,et al.Arginase-2, a miR-1299 target, enhances pigmentation in melasma by reducing melanosome degradation via senescence-induced autophagy inhibition[J].Pigment Cell Melanoma Res,2017,30(6):521-530.
[9] Urbanelli L, Buratta S, Sagini K,et al.Exosome-based strategies for Diagnosis and Therapy[J].Recent Pat CNS Drug Discov,2015,10(1):10-27.
[10] Campuzano-García AE, Torres-Alvarez B, Hernández-Blanco D,et al.DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo[J].Biomed Res Int, 2019,9068314.
[11] Kwon Soon-Hyo,Na Jung-Im,Choi Ji-Young,et al.Melasma: Updates and perspectives[J].Experimental dermatology,2019,28(6).
[12] Passeron T, Picardo M. Melasma, a photoaging disorder[J].Pigment Cell Melanoma Res,2018,31(4):461-465.
[13] Choi HR, Kang YA, Lee HS,et al.Disulfanyl peptide decreases melanin synthesis via receptor-mediated ERK activation and the subsequent downregulation of MITF and tyrosinase[J].Int J Cosmet Sci,2016,38(3):279-285.
[14] Kim M, Shibata T, Kwon S,et al.Ultraviolet-irradiated endothelial cells secrete stem cell factor and induce epidermal pigmentation[J].Sci Rep,2018,8(1):4235.
[15] Seo EY, Jin SP, Sohn KC,et al.UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes[J].J Invest Dermatol,2017,137(8):1757-1765.
[16] Taraz M, Niknam S, Ehsani AH.Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies[J]Dermatol Ther,2017,30(3):10.
[17] Cho YH, Park JE, Lim DS,et al.Tranexamic acid inhibits melanogenesis by activating the autophagy system in cultured melanoma cells[J].J Dermatol Sci,2017,88(1):96-102.
[18] Kohli I, Chaowattanapanit S, Mohammad TF, et al. Synergistic effects of long-wavelength ultraviolet A1 and visible light on pigmentation and erythema[J].Br J Dermatol,2018,178(5):1173-1180.
[19] Boukari F, Jourdan E, Fontas E, et al.Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial[J].J Am Acad Dermatol,2015,72(1):189-90.
[20] Randhawa M, Seo I, Liebel F,et al.Visible Light Induces Melanogenesis in Human Skin through a Photoadaptive Response[J].PLoS One,2015,10(6):1371.
[21] Ogbechie-Godec OA, Elbuluk N. Melasma: an Up-to-Date Comprehensive Review[J].Dermatol Ther (Heidelb),2017,7(3):305-318.
[22] Choubey V, Sarkar R, Garg V,et al.Role of oxidative stress in melasma: a prospective study on serum and blood markers of oxidative stress in melasma patients[J].Int J Dermatol,2017,56(9):939-943.
[23] Kwon SH, Hwang YJ, Lee SK,et al.Heterogeneous Pathology of Melasma and Its Clinical Implications[J].Int J Mol Sci,2016,17(6):824.
[24] Byun JW, Park IS, Choi GS,et al.Role of fibroblast-derived factors in the pathogenesis of melasma[J].Clin Exp Dermatol,2016,41(6):601-609.
[25] Kim M, Lee J, Park TJ, et al.Paracrine crosstalk between endothelial cells and melanocytes through clusterin to inhibit pigmentation[J].Exp Dermatol,2018,27(1):98-100.
[26] Regazzetti C, De Donatis GM, Ghorbel HH, et al. Endothelial Cells Promote Pigmentation through Endothelin Receptor B Activation[J].J Invest Dermatol,2015,135(12):3096-3104.
[27] Geddes ER, Stout AB, Friedman PM. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser[J].Lasers Surg Med,2017,49(1):20-26.
[28] Li JY, Geddes ER, Robinson DM,et al.A review of melasma treatment focusing on laser and light devices[J].Semin Cutan Med Surg,2016,35(4):223-232.
[29] Espósito ACC, Brianezi G, de Souza NP,et al.Exploring pathways for sustained melanogenesis in facial melasma: an immunofluorescence study[J].Int J Cosmet Sci,2018,40(4):420-424.
[30] Rodríguez-Arámbula A, Torres-álvarez B, Cortés-García D, et al.CD4, IL-17, and COX-2 Are Associated With Subclinical Inflammation in Malar Melasma[J].Am J Dermatopathol,2015,37(10):761-766.
[31] Gao YL, Jia XX, Wang M, et al. Melanocyte activation and skin barrier disruption induced in melasma patients after 1064nm Nd:YAG laser treatment[J].Lasers Med Sci,2019,34(4):767-771.
[32] Gautam M, Patil S, Nadkarni N,et al.Histopathological comparison of lesional and perilesional skin in melasma: A cross-sectional analysis[J].Indian J Dermatol Venereol Leprol,2019,85(4):367-373.
[33] Sarkar R, Ailawadi P, Garg S. Melasma in Men: A Review of Clinical, Etiological, and Management Issues[J].J Clin Aesthet Dermatol,2018,11(2):53-59.
[34] Cakmak SK, zcan N, KlA, et al. Etiopathogenetic factors, thyroid functions and thyroid autoimmunity in melasma patients[J].Postepy Dermatol Alergol,2015,32(5):327-330.
[35] Rostami Mogaddam M, Iranparvar Alamdari M, Maleki N,et al. Evaluation of autoimmune thyroid disease in melasma[J].J Cosmet Dermatol,2015,14(2):167-171.
[36] Rostami Mogaddam M, Safavi Ardabili N, Iranparvar Alamdari M, et al. Evaluation of the serum zinc level in adult patients with melasma: Is there a relationship with serum zinc deficiency and melasma[J].J Cosmet Dermatol,2018,17(3):417-422.
[37] Sohn E.Skin microbiota's community effort[J].Nature,2018,563(7732):S91-S93.
[38] Locci-Molina N,Wang A,Kroumpouzos G. Melasma Improving Spontaneously upon Switching from a Combined Oral Contraceptive to a Hormone-releasing Intrauterine Device: A Report of Four Cases[J].Acta Derm Venereol,2015,95(5):624-625.
[39] Cohen PR.Topical Anti-Estrogen Therapy To Treat Melasma[J].J Clin Aesthet Dermatol,2017,10(6):16.
[40] Cohen PR.Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor[J].Med Hypotheses,2017,101:1-5.

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

[1]	杜雅婷, 于文君, 李燕, 付元磊, 孙考祥.基于Golden Gate高效构建psiCHECK双荧光素酶报告基因的方法及应用[J]. betway必威登陆网址（betway.com ）学报, 2023, 44(3): 180-185.
[2]	尹硕, 郑晓红, 张维春柏, 李文斌, 陈峰.原发性中枢神经系统淋巴瘤的治疗现状与进展[J]. betway必威登陆网址（betway.com ）学报, 2023, 44(2): 86-92.
[3]	李爽爽, 邰晓鹏, 冯春苗.他汀类药物临床应用及处方合理性分析[J]. betway必威登陆网址（betway.com ）学报, 2023, 44(2): 106-109.
[4]	周晓丽, 胡顺凤, 王欣.精准医学时代治疗外周T细胞淋巴瘤的新型药物研究进展[J]. betway必威登陆网址（betway.com ）学报, 2023, 44(1): 1-9.
[5]	赵红冉, 崔彦.康柏西普治疗Biette结晶样视网膜病变合并脉络膜新生血管1例[J]. betway必威登陆网址（betway.com ）学报, 2022, 43(5): 375-378.
[6]	蔡晓雯, 梁英, 蒋东洋, 张琼, 葛亚龙.表现为肺炎的肺栓塞1例并文献分析[J]. betway必威登陆网址（betway.com ）学报, 2022, 43(3): 219-222.
[7]	段元青, 牛惠, 张新焕, 付燕.肠道菌群与青少年肥胖相关性研究进展[J]. betway必威登陆网址（betway.com ）学报, 2022, 43(12): 958-962.
[8]	薛俊莉, 司艳红, 秦树存.老年动脉粥样硬化性心血管疾病患者长期使用他汀类药物和阿司匹林的安全隐患[J]. betway必威登陆网址（betway.com ）学报, 2022, 43(11): 870-875.
[9]	王春晓, 王峰, 李明伟, 王守恩, 刘宝军.2016—2020年某院尿路感染病原菌耐药性变迁与使用抗菌药物的频度相关性[J]. betway必威登陆网址（betway.com ）学报, 2022, 43(10): 760-764.
[10]	徐雯, 张敬军.大麻二酚治疗癫痫的研究进展[J]. betway必威登陆网址（betway.com ）学报, 2022, 43(1): 74-77.
[11]	翟玉喜, 冯娜, 高建鲁, 汪鑫.原发性开角型青光眼患者泪液及血清中BDNF的定量分析[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(7): 516-520.
[12]	曹慧, 刘勇, 郑成彩.鼻内镜手术联合药物治疗慢性鼻窦炎伴鼻息肉的临床效果[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(6): 451-453.
[13]	李志鹏, 李伟明.加味四君子汤联合三联药物治疗Hp相关胃十二指肠溃疡的疗效[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(6): 436-438.
[14]	王林丽.密集型银质针结合药物治疗颈肩腰腿痛的临床效果研究[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(2): 148-150.
[15]	赵春晖, 李占斌, 辛静昕, 张新焕, 高聆.Prader-Willi综合征代谢表型与遗传研究进展[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(12): 941-946.